Hydatidiform mole and trophoblastic tumors. Standards and innovation of diagnosis and treatment
Vol. 60 No. 3 (2014), Articles
Vol. 60 No. 3 (2014)

Hydatidiform mole and trophoblastic tumors. Standards and innovation of diagnosis and treatment

Articles
https://doi.org/10.37469/0507-3758-2014-60-3-396-401
Published 15.12.2014
National Cancer Institute
##article.numberofdownloads## 200
##article.numberofviews## 211
PDF (Русский)

Keywords

hydatidiform mole
malignant trophoblastic tumors

How to Cite

(2014). Hydatidiform mole and trophoblastic tumors. Standards and innovation of diagnosis and treatment. Voprosy Onkologii, 60(3), 396–401. https://doi.org/10.37469/0507-3758-2014-60-3-396-401
ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver

Abstract

Malignant trophoblastic tumors are hormone and hormone-dependent allografts initiated by, in the most cases, hydatidiform mole. The absence of methodological principles for monitoring of women after evacuation of hydatidiform mole often leads to late detection of the disease, inadequate chemotherapy conducted in clinics with no experience of treatment, followed by the development of drug-resistant tumors and worse prognosis. This paper analyzes the problem at the moment.
https://doi.org/10.37469/0507-3758-2014-60-3-396-401
##article.numberofdownloads## 200
##article.numberofviews## 211
PDF (Русский)

References

Мещерякова Л.А. Стандартное лечение трофобластической болезни // Практ. онкол. - 2008. - Т. 9. - № 3. - С. 160-170.

Цип Н.П. Трофобластическая болезнь беременности. Практическая онкогинекология / Под ред. проф. Л.И. Воробьевой - К., 2012. - Гл. 6. - С. 139-174.

Цип Н.П., Воробьева Л.И. Мониторинг больных после удаления пузырного заноса // Клин. онкол. - 2012. - № 8(4). - С. 81-84.

Цип Н.П., Воробьева Л.И. Клинические особенности злокачественных трофобластических опухолей, инициированных пузырным заносом, у женщин разных возрастных групп // Клин. онкол. - 2013. - № 1(9). - С. 53-55.

Цип Н.П., Орел В.Э., Романов А.В., Дзятковская Н.Н. Теория динамического хаоса и злокачественные процессы (Злокачественные опухоли трофобласта) // Радиочастотная гипертермия злокачественных новообразований, нанотехнологии и динамический хаос / В.Э. Орел, И.Б. Щепотин, И.И. Смоланка и др. - Тернополь: ТГМУ, 2012. - Гл. 3. - С. 138-157.

Berkowitz R.S., Goldstein D.P. Clinical practice. Molar pregnancy // N. Engl. J. Med. - 2009. - Vol. 360. - P. 1639-1645.

Berkowitz R.S., Goldstein D.P. Current management of gestational trophoblastic diseases // Gynecol. Oncol. - 2009. - Vol. 112. - P. 654-662.

Berkowitz R.S., Goldstein D.P. Current advances in the management of gestational trophoblastic disease // Gynecol. Oncol. - 2013. - Vol. 128. - P. 3-5.

Kohorn E.I. Dynamic staging and risk factor scoring for gestational trophoblastic disease // Int. J. Gynecol. Cancer. - 2007. - Vol. 17. - Р. 1124-1130.

Kohorn E. Problems with the nomenclature, staging and risk factor scoring of gestational trophoblastic disease // CME J. Gynecol. Oncol. - 2011. - 91 р.

Lurain J.R. Gestational trophoblastic disease I: epidemiology, pathology, clinical presentation and diagnosis of gestational trophoblastic disease, and management of hydatidiform mole // Am. J. Obstet. Gynecol. - 2010. - Vol. 203. - Р. 531-539.

Lybol C., Sweep P.C., Harvey R. et al. Relapse rates after two versus three consolidation courses of methotrexate in the treatment of low-risk gestational trophoblastic neoplasia // Gynecol. Oncol. - 2012. - Vol. 125. - P. 576-579.

Ngan H.Y. The practicability of FIGO 2000 staging for gestational trophoblastic neoplasia // Int. J. Gynecol. Cancer. - 2004. - Vol. 14. - № 2. - P. 202-205.

Pezeshki M., Hancock B.W., Silcocks P. et al. The role of repeat uterine evacuation in the management of persistent gestational trophoblastic disease // Gynecol. Oncol. - 2004. - Vol. 95. - P. 423-429.

Sebire N.J., Foskett M., Paradinas F.J. et al. Outcome of twin pregnancies with complete hydatidiform mole and healthy co-twin // Lancet. - 2002. - Vol. 359. - P. 2165-2166.

Seckl M.J., Sebire N.J., Berkowitz R.S. Gestational trophoblastic disease // Lancet. - 2010. - Vol. 376. - P. 717-729.

Seckl M.J., Sebire N.J., Fisher R.A. et al. Gestational trophoblastic disease: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up // Ann. Oncol. - 2013. - Vol. 24 (Suppl. 6). - P. 39-50.

Soares P.D., Maest I., Costa O.L. et al. Geographical distribution and demographic characteristics of gestational trophoblastic disease // J. Reprod. Med. - 2010. - Vol. 55. - Р. 305-310.

Soper J. Гестационная трофобластическая болезнь. Клиническая онкогинекология / Под. ред. Ф.Дж. Дисаи, У.Т. Крисмана / Пер. с англ. под ред. Е.Г. Новиковой. - М.: Практ. мед. - 2012. - Т. 2. - С. 180-221.

Van Trommel N.E., Goldfier F., Lybol C. et al. Introduction of a Pan European initiative to improve clinical management of GTD in Europe: European Organisation for Treatment of Trophoblastic Disease // CME J. - 2011. - 62 р.

Van Trommel N.E., Massuger L.F., Verheijen R.H. et al. The curative effect of a second curettage in persistent trophoblastic disease: a retrospective cohort survey // Gynecol. Oncol. - 2005. - Vol. 99. - P. 6-13.

All the Copyright statements for authors are present in the standart Publishing Agreement (Public Offer) to Publish an Article in an Academic Periodical 'Problems in oncology' ...